Anumantha G Kanthasamy Selected Research

diapocynin

11/2014	A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.
8/2013	Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.
10/2012	Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anumantha G Kanthasamy Research Topics

Disease

53	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2003
16	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 08/2005
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2003
13	Inflammation (Inflammations) 01/2022 - 11/2009
9	Neuroinflammatory Diseases 01/2019 - 04/2012
6	Scrapie 01/2020 - 09/2006
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2017 - 09/2006
5	Synucleinopathies 01/2021 - 07/2017
4	Parkinsonian Disorders (Parkinsonism) 01/2021 - 07/2017
3	Nervous System Diseases (Neurological Disorders) 01/2018 - 04/2005
2	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 01/2020
2	Dementia (Dementias) 01/2021 - 01/2019
2	Wounds and Injuries (Trauma) 10/2020 - 07/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2020 - 07/2017
2	Gliosis 01/2019 - 01/2018
2	Seizures (Absence Seizure) 01/2018 - 01/2018
2	Anosmia 11/2014 - 07/2014
1	Dysbiosis 01/2022
1	Pneumonia (Pneumonitis) 06/2021
1	Bites and Stings (Sting) 05/2021
1	Endotoxemia 08/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Dystonia (Limb Dystonia) 01/2019
1	Pathologic Processes 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Vector Borne Diseases 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Weight Loss (Weight Reduction) 11/2017
1	Blast Injuries 07/2017
1	Shock 07/2017

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
12	Phosphotransferases (Kinase)IBA 01/2021 - 08/2005
12	ManganeseIBA 12/2019 - 04/2005
11	SynucleinsIBA 12/2020 - 02/2011
7	acetovanillone (apocynin)IBA 01/2021 - 10/2012
7	Protein Kinases (Protein Kinase)IBA 01/2016 - 11/2006
6	InflammasomesIBA 01/2021 - 01/2017
6	IronIBA 06/2018 - 09/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
5	Protein Kinase C-deltaIBA 01/2021 - 08/2005
5	PrionsIBA 01/2020 - 09/2006
5	MetalsIBA 12/2019 - 06/2010
5	AntioxidantsIBA 01/2018 - 09/2006
4	Neuroprotective AgentsIBA 01/2022 - 09/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 03/2002
4	EnzymesIBA 01/2021 - 11/2009
4	alpha-SynucleinIBA 01/2021 - 09/2005
4	Prion ProteinsIBA 11/2017 - 09/2006
4	UbiquitinIBA 08/2009 - 09/2006
4	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2009 - 09/2006
3	CytokinesIBA 01/2021 - 11/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020 - 04/2012
3	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 09/2006
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
3	diapocyninIBA 11/2014 - 10/2012
2	RotenoneIBA 01/2022 - 01/2017
2	PesticidesIBA 01/2022 - 01/2019
2	Cytochromes c (Cytochrome c)IBA 05/2021 - 03/2002
2	Small Interfering RNA (siRNA)IBA 05/2021 - 01/2019
2	src-Family KinasesIBA 08/2020 - 01/2018
2	Biological ProductsIBA 12/2019 - 01/2018
2	Retinaldehyde (Retinal)IBA 01/2019 - 07/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2009
2	Protein AggregatesIBA 10/2018 - 10/2011
2	HepcidinsIBA 06/2018 - 01/2016
2	Kainic Acid (Kainate)IBA 01/2018 - 01/2018
2	Protein Kinase CIBA 01/2017 - 09/2007
2	Leucine (L-Leucine)FDA Link 11/2014 - 08/2013
2	Divalent CationsIBA 01/2014 - 09/2006
2	Protein Isoforms (Isoforms)IBA 10/2011 - 09/2007
2	DieldrinIBA 10/2008 - 08/2005
2	NeurotoxinsIBA 10/2008 - 06/2007
2	Caspase 3 (Caspase-3)IBA 11/2006 - 03/2002
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 05/2021
1	Particulate MatterIBA 05/2021
1	EndoribonucleasesIBA 01/2021
1	salubrinalIBA 01/2021
1	Inositol (Myoinositol)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Activating Transcription Factor 4IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	NeuropeptidesIBA 10/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2020
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	AntibodiesIBA 02/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	HMGB1 Protein (HMG1)IBA 01/2019
1	ethyl pyruvateIBA 01/2019
1	saracatinibIBA 01/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2017

Therapy/Procedure

2	Therapeutics 04/2015 - 08/2014
1	Behavior Control 01/2018
1	Compressed Air 07/2017